The prognostic value of cancer stem cell markers in thyroid cancer: a systematic review-Reference-Cited by-同舟云学术

The prognostic value of cancer stem cell markers in thyroid cancer: a systematic review

Published:2024-03-11 Issue:2 Volume:20 Page:686-690
ISSN:1734-1922
Container-title:Archives of Medical Science
language:
Short-container-title:Arch Med Sci

Author:

Peng Xingqiao¹,Zhu Peiye²,Zhang Qiang¹²,Li Jin¹

Affiliation:

1. Department of Oncology, Army Medical Center of PLA, Chongqing, China

2. College of Pharmacy and Bioengineering, Chongqing University of Technology, Chongqing, China

Abstract

IntroductionThyroid cancer stem cells (TCSCs) play a crucial role in the pathogenesis, metastasis, and therapeutic response of thyroid cancer, making them promising biomarkers and potential targets for clinical intervention. This systematic review aims to qualitatively assess the impact of commonly used TCSC markers on the prognosis of thyroid cancer using qualitative methods.Material and methodsIn total, the analysis encompassed five articles.ResultsSix TCSC markers were involved, among which CD133, CD44, CD24, CD15 and ALDH1 were associated with the prognosis of thyroid cancer.ConclusionsHowever, the utility of these TCSC markers in clinical practice for predicting the prognosis of thyroid cancer requires further research to provide additional evidence supporting their effectiveness.

Publisher

Termedia Sp. z.o.o.

Link

https://www.archivesofmedicalscience.com/pdf-185169-109426

Reference20 articles.

1. Pellegriti G, Frasca F, Regalbuto C, Squatrito S, Vigneri R. Worldwide increasing incidence of thyroid cancer: update on epidemiology and risk factors. J Cancer Epidemiol 2013; 2013: 965212.

2. Kitahara CM, Sosa JA. The changing incidence of thyroid cancer. Nat Rev Endocrinol 2016; 12: 646-53.

3. Edafe O, Wadsley J, Harrison BJ, Balasubramanian SP. Treatment related morbidity in differentiated thyroid cancer-a survey of clinicians. Thyroid Res 2014; 7: 3.

4. Wang J, Xiang C, Cai Y, et al. Clinicopathological and prognostic significance of COX-2 in glioma patients: a meta-analysis. Arq Neuropsiquiatr 2022; 80: 1254-61.

5. Lu L, Wu M, Sun L, et al. Clinicopathological and prognostic significance of cancer stem cell markers CD44 and CD133 in patients with gastric cancer: a comprehensive meta-analysis with 4729 patients involved. Medicine (Baltimore) 2016; 95: e5163.